Navigation Links
Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research
Date:1/6/2009

NEW YORK, Jan. 6 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation awarded a total of about $2.7 million to four industry research teams for pre-clinical research on potential new treatments for Parkinson's disease.

The funding was awarded under the Foundation's Therapeutics Development Initiative. This program, first launched in 2006, supports and bolsters industry-focused efforts on Parkinson's research. TDI is part of MJFF's focus on 'de-risking' preclinical PD research for biotech and pharmaceutical companies, thus expanding and catalyzing industry investments in Parkinson's drug development. By adding MJFF resources to companies' own, the Foundation aims to make Parkinson's therapies a more attractive bet and help to push research further along the pipeline.

The funded projects are listed below. Full information, including grant abstracts and researcher bios, is available on the Foundation's Web site -- www.michaeljfox.org.

Cerebrospinal Fluid (CSF) Biomarkers of Microtubule-mediated Axonal Transport for Monitoring of Disease Progression and Therapeutics Interventions in Parkinson's Disease

Patrizia Fanara, Ph.D., KineMed, Inc.

Selective Inhibition of Cyclic Nucleotide Phosphodiesterase Type 7 (PDE7): A Novel and Efficacious Approach to Treating Parkinson's Disease

Vincent Allen Florio, Ph.D., Omeros Corporation

Development of ER-beta Agonists for the Treatment of Parkinson's Disease

Roger Olsson, Ph.D., and Krista McFarland, Ph.D., Acadia Pharmaceuticals, Inc.

Multiphosphatase Inhibitors as Therapeutics for Parkinson's Disease

Arnon Rosenthal, Ph.D., and Franz F. Hefti, Ph.D., ShanaRX

About The Michael J. Fox Foundation

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within the decade through an aggressively funded research agenda. The Foundation has funded over $130 million in research to date.


'/>"/>
SOURCE Michael J. Fox Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
2. Michael J. Fox Foundation Commits Up to $3 Million for Clinical Trials That Can Improve Treatment of Parkinsons Disease
3. New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinsons Clinical Trials
4. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
5. Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine
6. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
7. Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinsons Disease
8. Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinsons Therapeutics
9. Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee
10. Michael J. Fox Foundation Funds $1.1 Million for Cutting-Edge Approaches to Parkinsons Disease Under Rapid Response Innovation Awards 2008
11. Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... GAITHERSBURG, Md. , July 10, 2017 ... in non-animal test methods, is the recipient of a ... by the PETA International Science Consortium. The device, which ... be used to expose human lung cells to airborne ... lung. IIVS will use the VITROCELL® system for testing ...
(Date:7/5/2017)... MANCHESTER, England , July 5, 2017 ... the perfect answer as physics and manufacturing combine to progress ... the thyroid, existing SPECT systems are unable to accurately quantify ... consequence, only limited information regarding the success of this radiotherapy ... ...
(Date:6/30/2017)... -- In vitro diagnostics market firm Kalorama Information has ... ten diagnostic companies have successfully completed financings.  The types ... loan facility.  The size of these financings ranged from ... provides a monthly IVD Market Trends Report ... "Diagnostics deals are ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... ... financial consultation services to families and business owners in the Dalton region, is ... support for children overcoming sexual assault and physical abuse. , The GreenHouse is ...
(Date:7/21/2017)... ... ... The Ellis Agency, an eastern Georgie provider of insurance management and financial ... event with the goal of bringing in support for epilepsy patients in the greater ... recently launched a charity campaign of her own by donating her birthday to the ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... and financial planning services to communities in the greater Birmingham area, is joining ... resources to underprivileged young people in the region. , The Chris Hammond Youth ...
(Date:7/21/2017)... ... July 21, 2017 , ... Fresh Wave® IAQ today announced the launch of ... colleges and universities at the APPA 2017 Annual Conference and Exhibition in ... smoke odors without the use of harsh chemicals, Fresh Wave IAQ Smoke Away Air ...
(Date:7/21/2017)... Connecticut (PRWEB) , ... July 21, 2017 , ... Hospital ... from HealthCareMandA.com . The number of hospital acquisitions rose to 23 in the ... of 2017, and up 15% from the 20 announced deals in the year-ago second ...
Breaking Medicine News(10 mins):